Eric Neibart
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
Papers in
-
- Tuberculosis Research and Epidemiology 2
- Antifungal resistance and susceptibility 2
- COVID-19 Clinical Research Studies 2
- HIV/AIDS drug development and treatment 2
- Virology 1
- Co-authors
- Burt R. MeyersMeryl H. MendelsonPatricia A. SheinerCharles M. MillerJeffrey P. GumprechtTony CheungSusan SzaboAlejandra Gurtman
- Journals
- Clinical Infectious Diseases (3 papers)Journal of the American College of Cardiology (2 papers)International Journal of STD & AIDS (1 paper)Circulation Heart Failure (1 paper)Journal of NeuroVirology (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Eric Neibart
13 papers receiving 373 citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 186
- Applied Microbiology and Biotechnology 12
- Molecular Medicine 28
- Microbiology 4
- Epidemiology 172
Countries citing papers authored by Eric Neibart
This map shows the geographic impact of Eric Neibart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Neibart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Neibart more than expected).
Fields of papers citing papers by Eric Neibart
This network shows the impact of papers produced by Eric Neibart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Neibart. The network helps show where Eric Neibart may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Neibart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2020 | 22 | |
| 5 | 2020 | 73 | |
| 6 | 2018 | 10 | |
| 7 | 2006 | 22 | |
| 8 | 1994 | 79 | |
| 9 | 1994 | 112 | |
| 10 | 1993 | 11 | |
| 11 | Antifungal agents and the treatment of fungal infections of the head and neck. | 1993 | 11 |
| 12 | 1993 | 10 | |
| 13 | 1992 | 10 | |
| 14 | 1988 | 24 |
About Eric Neibart
Eric Neibart is a scholar working on Infectious Diseases, Virology, Epidemiology, Microbiology and Parasitology, having authored 14 papers that have together received 390 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Cardiac Valve Diseases and Treatments (3 papers), Tuberculosis Research and Epidemiology (2 papers), Antifungal resistance and susceptibility (2 papers), COVID-19 Clinical Research Studies (2 papers), HIV/AIDS drug development and treatment (2 papers), Acute Myocardial Infarction Research (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Infectious Diseases (186 citations), Applied Microbiology and Biotechnology (12 citations), Molecular Medicine (28 citations), Microbiology (4 citations) and Epidemiology (172 citations). Eric Neibart has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Burt R. Meyers, Meryl H. Mendelson, Patricia A. Sheiner, Charles M. Miller, Jeffrey P. Gumprecht, Tony Cheung, Susan Szabo, Alejandra Gurtman, Kyung H. Choi and Shalom Z. Hirschman. Their work appears in journals such as Clinical Infectious Diseases, Journal of the American College of Cardiology, International Journal of STD & AIDS, Circulation Heart Failure and Journal of NeuroVirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.